AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Science, Spoken
Not Everyone Loses Weight on Ozempic
Jul 2, 2024
Exploring the variability in weight loss responses to GLP-1 drugs, researchers delve into genetic variations and physiological factors. Factors affecting weight loss and obesity phenotypes are discussed, including how machine learning categorizes individuals for enhanced benefits from GLP-1 drugs.
09:11
AI Summary
Highlights
AI Chapters
Episode notes
Podcast summary created with Snipd AI
Quick takeaways
- Effectiveness of GLP-1 drugs varies due to genetics and metabolism.
- Commitment to lifestyle changes and adherence to medication play key roles in weight loss outcomes.
Deep dives
Variability in Response to Anti-Obesity Drugs
Not all patients experience significant weight loss on GLP-1 drugs like Ozempic and Wigovi. Clinical trials show around 15-20% weight loss on average, but real-world results vary. Factors such as genetics, metabolism, and other medications can influence the effectiveness of these drugs. While some individuals benefit greatly, others may not respond well and could experience side effects that outweigh the minimal weight loss.
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode